| Name | Recombinant Human KIR2DL2/CD158b1 Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 3015-KR |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Human KIR2DL2 (His22 - His245) Accession # P43627 IEGRMD Human IgG 1 (Pro100 - Lys330) N-terminus C-terminus |
| Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain |
| Bioactivity | Measured by its ability to bind HEK293T human embryonic kidney cells in a flow cytometry assay. When 1 μg of Recombinant Human KIR2DL2/CD158b1 Fc Chimera is added to 5 x 10 5 HEK293T cells, >20% of the cells will bind to the protein. |
| Endotoxin | <1.0 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | P43627 |
| Gene | KIR2DL2 |
| Sequence | His22 |
| Supplier Page | Shop |
Cassidy S, Mukherjee S, Myint TM, Mbiribindi B, North H, Traherne J, Mulder A, Claas FH, Purbhoo MA, Das J, Khakoo SI. Eur J Immunol. 2015 Feb;45(2):492-500.
Fadda L, Korner C, Kumar S, van Teijlingen NH, Piechocka-Trocha A, Carrington M, Altfeld M. PLoS Pathog. 2012;8(7):e1002805.